Replies to post #2888 on ImClone Systems Inc (formerly IMCL)

[Imclonian]

I really don't see Erbitux+Tarceva in lung producing any statistically significant results IMO. I would assume oncs would pick either erbitux or tarceva, but not both because I don't see much improvement by adding a 2nd drug.